In this study, we identified ARHGEF16 as a target gene of GLI2 that interacts with cytoskeleton-associated protein 5 (CKAP5) to regulate glioma cell migration and proliferation, thus promoting glioma progression. The gene discussed is CKAP5; the disease is central nervous system cancer.